Immunological effectiveness of mass vaccine prophylaxis against hepatitis B within the framework of the National Priority Project "Health" in some regions of the Russian Federation

  • Authors: Shulakova N.I1, Lytkina I.N1, Akimkin V.G2,3,4, Ershova O.N5, Shahgildyan I.V5, Kisteneva L.B5, Kuzina L.E6, Chernyavskaya O.P7
  • Affiliations:
    1. Municipal Consultative and Disgnostic Centre of Specific Immunological Prevention
    2. Reseasrch Institute of Disinfectology of Federal Service on Customers' Rights Protection and Human Well-Being Surveillance
    3. Central Research Institute of Epidemiology of Federal Service on Customers’ Rights Protection and Human Well-Being Surveillance
    4. State Educational Institution of Higher Professional Training, I.M. Sechenov First Moscow State Medical University
    5. Research Center of Epidemiology and Microbiology Center named after Academician N.F. Gamaleya
    6. Infection Clinical Hospital № 1 of Department of Healthcare in Moscow
    7. Federal Centre for Hygiene and Epidemiology Federal Service on Customers’ Rights Protection and Human Well-Being Surveillance
  • Issue: Vol 20, No 4 (2015)
  • Pages: 4-7
  • Section: Articles
  • Submitted: 23.07.2020
  • Published: 15.08.2015
  • URL: https://rjeid.com/1560-9529/article/view/40845
  • DOI: https://doi.org/10.17816/EID40845
  • ID: 40845
  • Retraction date: 12.01.2026
  • Retraction reasons description:

    The reason for retraction is simultaneous publication in another journal without the publishers’ consent. Similar article: Shulakova NI, Lytkina IN, Akimkin VG, et al. Immunological effectiveness of mass vaccination against hepatitis B within the framework of the priority national project "Health" in certain regions of the Russian Federation". Public Health and Life Environment – PH&LE. 2015;(6):39-43. EDN: UCHPWN. The editors found of the publication of a similar article through their own work procedures for assessing the journal's scientometric indicators. It was not possible to reliably determine to which journal the article was previously submitted using available methods. Therefore, a decision was made to retract the article from the journal "Epidemiology and Infectious Diseases".



Cite item

Full Text

Abstract

Immunological efficacy of mass vaccine prevention of hepatitis B was studied in the framework of the National Priority Project "Health" in some regions of the Russian Federation. Markers of hepatitis B (HbsAg, anti-HBs with the determination of their concentration, anti-HBcor summary and class IgM) were determined with the use of commercial test systems by chemiluminescence enzyme immunoassay analyzer the "Architect" of the company «Abbott» (USA) at different times after the completion of vaccination

About the authors

N. I Shulakova

Municipal Consultative and Disgnostic Centre of Specific Immunological Prevention

Author for correspondence.
Email: info@eco-vector.com

канд. мед. наук, зав. отделением.

16, Uspensky bystr., Moscow, Russian Federation, 127006

I. N Lytkina

Municipal Consultative and Disgnostic Centre of Specific Immunological Prevention

Email: info@eco-vector.com

доктор мед. наук, зам. гл. врача по эпид. вопросам

16, Uspensky bystr., Moscow, Russian Federation, 127006

V. G Akimkin

Reseasrch Institute of Disinfectology of Federal Service on Customers' Rights Protection and Human Well-Being Surveillance; Central Research Institute of Epidemiology of Federal Service on Customers’ Rights Protection and Human Well-Being Surveillance; State Educational Institution of Higher Professional Training, I.M. Sechenov First Moscow State Medical University

Email: info@eco-vector.com

член-корр. РАН, доктор мед. наук, проф., зам. директора, зав. кафедрой дезинфектологии ИПО

18, Nauchny pr., Moscow, Russian Federation, 117246

O. N Ershova

Research Center of Epidemiology and Microbiology Center named after Academician N.F. Gamaleya

Email: info@eco-vector.com

D.I. Ivanovsky Research Institute of Virology

16, Gamalei st, Moscow, Russian Federation, 123098

I. V Shahgildyan

Research Center of Epidemiology and Microbiology Center named after Academician N.F. Gamaleya

Email: info@eco-vector.com

D.I. Ivanovsky Research Institute of Virology

16, Gamalei st, Moscow, Russian Federation, 123098

L. B Kisteneva

Research Center of Epidemiology and Microbiology Center named after Academician N.F. Gamaleya

Email: info@eco-vector.com

D.I. Ivanovsky Research Institute of Virology

16, Gamalei st, Moscow, Russian Federation, 123098

L. E Kuzina

Infection Clinical Hospital № 1 of Department of Healthcare in Moscow

Email: info@eco-vector.com

канд. мед. наук, врач клинической лабораторной диагностики, клинико-диагностической лаб.

63, Volokolamskoe shosse, Moscow, Russian Federation, 125367

O. P Chernyavskaya

Federal Centre for Hygiene and Epidemiology Federal Service on Customers’ Rights Protection and Human Well-Being Surveillance

Email: info@eco-vector.com

канд. мед. наук, зав. отделом обеспечения эпидемиологического надзора

19-а, Varshavskoe Shosse, Moscow, Russian Federation, 117105

References

  1. Онищенко Г.Г.Актуальные проблемы профилактики инфекционных болезней на современном этапе. Журнал микробиологии, эпидемиологии ииммунологии. 2010; 4: 13-22.
  2. О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2013 году: Государственный доклад. М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека; 2014.
  3. Балаян М.С., Михайлов М.И. Энциклопедический словарь вирусные гепатиты. 1999.
  4. Брико Н.И. Критерии оценки эффективности вакцинации. Лечащий врач. 2001; 3.
  5. Флетчер Р., Флетчер С., Вагнер Э. Клиническая эпидемиология (основы доказательной медицины). М.: Медиа Сфера; 1998.
  6. Fedson David S. Measuring protection: efficacy vs effectiveness. Pasteur Merieux MSD Lyon.
  7. Бектмиров Т.А. Успехи и проблемы вакцинопрофилактики гепатита В в мире. Вакцинация. 2001; 3 (15).
  8. Результаты регистрационных испытаний вакцины «Эувакс» для профилактики гепатита В / Т.А. Бектимиров, М.А. Горбунов, Н.В. Шалунова. Вакцинация. Информационный бюллетень. 1999; 4: 8-9.
  9. Щукина И.А., Ходякова И.А., Хитрова Р.И. и др. Иммунологическая эффективность вакцинации медицинского персонала и детей закрытого учреждения против гепатита В вакциной «Энджерикс В». Мир вирусных гепатитов. 2004; 5: 11.
  10. Лучинина С.В., Уральшина Н.П., Кузьмина Г.И. Эффективность вакцинопрофилактики у медицинских работников г. Челябинска. Мир вирусных гепатитов. 2004; 5: 6.
  11. Пенкина Т.В., Чупыра Т.М., Гурбатова Т.Ю. и др. Широта распространенности маркеров гепатита В среди медицинского персонала многопрофильного стационара и определение напряженности поствакцинального иммунитета. Мир вирусных гепатитов. 2006; 6: 11-7.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Eco-vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80652 от 15.03.2021 . Учредитель ООО "Эко-Вектор Ай-Пи" (ОГРН 1157847215338).